Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin converting enzyme inhibitor therapy.

G Róna1

  • 1First Department of Medicine (Cardiology), Municipal Hospital Ajka, Hungary.

Therapia Hungarica (English Edition)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of MDCT in determining the perinephric fat tissue and renal sinus invasion in patients with clear cell renal cell carcinoma.

Nigerian journal of clinical practice·2021
Same author

Lymphoma in a pelvic spleen: CT features.

Journal of computer assisted tomography·1989
Same author

[Criteria and incidence of polymyalgia rheumatica].

Orvosi hetilap·1989
Same author

Neutrophil elastase alpha 1-proteinase inhibitor complexes in pleural effusions.

Klinische Wochenschrift·1988
Same author

Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage.

Arthritis and rheumatism·1987
Same author

[Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].

Wiener klinische Wochenschrift·1986

Angiotensin converting enzyme (ACE) inhibitors reduce vasoconstriction and aid vasodilation, offering new therapeutic options for hypertension and heart failure. Captopril shows promise in early heart failure and various other conditions.

Area of Science:

  • Pharmacology
  • Cardiology
  • Nephrology

Background:

  • Angiotensin converting enzyme (ACE) inhibitors modulate the renin-angiotensin system.
  • They decrease angiotensin II production and reduce the breakdown of vasodilatory kinins.
  • Available ACE inhibitors include captopril, enalapril, and lisinopril, with captopril being the only one currently marketed in Hungary.

Purpose of the Study:

  • To review the therapeutic applications of ACE inhibitors.
  • To highlight the role of captopril in managing hypertension and heart failure.
  • To discuss the efficacy and potential uses of ACE inhibitors in various clinical scenarios.

Main Methods:

  • Literature review of ACE inhibitor therapy.
  • Analysis of clinical data on captopril and other ACE inhibitors.

Related Experiment Videos

  • Discussion of pharmacological mechanisms and therapeutic outcomes.

    • Main Results:

    • ACE inhibitors are effective in treating hypertension and congestive heart failure.
    • Captopril demonstrates efficacy in early-stage heart failure, potentially slowing disease progression.
    • ACE inhibitors show promise in angina pectoris, prevention of myocardial infarction-related arrhythmias, and treatment of renal diseases, including diabetic nephropathy.

    Conclusions:

    • ACE inhibitors represent a significant advancement in cardiovascular and renal therapy.
    • Captopril offers a valuable treatment option, particularly in early heart failure.
    • Further research and clinical application of ACE inhibitors are warranted for various conditions.